+156.7%
MRNA vs AS
+134.9%
+21.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.3% | +0.5% | +4.8% | +5.1% |
| 7D | +14.6% | +6.9% | +7.7% | +12.2% |
| 30D | +29.4% | +16.0% | +13.4% | +23.3% |
| 3M | +371.9% | -12.8% | +384.8% | +395.8% |
| 6M | +421.0% | -15.4% | +436.4% | +450.0% |
| YTD | +762.0% | -15.7% | +777.7% | +804.6% |
| 1Y | +944.8% | +6.1% | +938.7% | +919.4% |
| All | +156.7% | +134.9% | +21.9% | +94.1% |
Cumulative growth
Daily Returns
Daily percentage return beside AS.
Daily Out/Under-Performance
Portfolio return minus AS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling